Inside Innovation

Seattle is on the rise as one of biopharma’s hottest spaces in cell and gene therapy. The BioForest region of Washington and Oregon continues to

Seattle-based biotech startup, Immusoft received the green light to start clinical trials to treat MPS I, a rare, lethal childhood disease. This approval makes it

Vilya Inc., the newest spinout from the University of Washington’s Institute of Protein Design (IPD), raised $50 million in a series A funding round. Vilya

Ora Biomedical is planting roots in the Puget Sound region with plans to open a drug-discovery laboratory. The company recently announced a $500,000 pre-seed round

Seattle-based mental health startup Alongside has received $5.5 million in seed funding, with plans to partner with schools to support adolescent mental health and continue

Preclinical biotech company Sonoma Biotherapeutics has announced plans to build an 83,000-square-foot manufacturing and research center on Seattle’s waterfront. The new facility will be used

Pattern Computer, a Seattle-based startup, is developing a rapid COVID-19 test based on patterns in light from spit. In its seven years as a company,

Monod Bio, a spinout company from the University of Washington’s Institute for Protein Design, has raised $25 million to develop molecular biosensors designed to detect

Violett, a Seattle-based startup specializing in ultraviolet light air purification technology, has raised $2.3 million in a seed funding round led by Tacoma Venture Fund.

Woodinville-based biotech Nortis has raised $6 million in equity funding and is seeking to raise an additional $3.5 million. Nortis focuses on “organ-on-chip” technology and

Seattle-based startup HDT Bio received nearly $1.8 million from the U.S. Army to develop a nasal spray designed to treat a variety of respiratory diseases.

Seattle’s SEngine Precision Medicine has raised $10 million in a new funding round led by The Washington Research Foundation. The new capital will be used